| Application no. and date | 21863656.1 (espacenet) (Federated) (European Patent Register), 20210902 | | Patent/reg. no. and date | DK/EP 4062913, 20240508 | | Publication date | 20220928 | | Priority no. and date | CN 202010910072, 20200902 | | EP pub. no. and date |
EP 4062913 20220928 | | Effective date | | | Applicant/owner | Beijing Biostar Pharmaceuticals Co., Ltd., Suite 310, Building 3
No. 88 Kechuang 6th Street
Beijing 101111, CN,
CHENGDU BIOSTAR PHARMACEUTICALS, LTD., No. 308 Kang Qiang 2nd Road
Chengdu High Technology Zone
Chengdu
Sichuan 611730, CN | | Applicant ref. no. | | | Inventor | TANG, Li,
Beijing 101111, CN,
QIU, Rongguo,
Beijing 101111, CN,
ZHANG, Chuan,
Sichuan 611730, CN | | Representative | | | Opponent | | | IPC Class | A61K 31/427 (2006.01) , A61K 47/30 (2006.01) , A61K 9/20 (2006.01) , A61K 9/22 (2006.01) , A61K 9/50 (2006.01) , A61P 35/00 (2006.01) | | Title | SOLID ORAL FORMULATION OF UTIDELONE | | Int. application no. | CN2021116194 | | Int. publication no. | WO2022048592 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
